Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.

K. L. Yip, S. Y. Chan, Wai Kee Eddie Ip, Y. L. Lau

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Bruton's tyrosine kinase (BTK) is involved in B-cell development. Mutation of BTK results in X-linked agammaglobulinemia (XLA). BTK is expressed in most haemopoietic lineages except mature T cells and plasma cells. We identified six novel and two known mutations of BTK in 11 Chinese XLA patients from 8 families. Family 1 had a novel point mutation at the start codon (135G-->T) in exon 2. Family 2 had known mutation of single A insertion in a stretch of 7 A residues (341-347insA) recognized as mutation hotspot in exon 3. Family 3 had a novel point mutation in exon 11 (1074A-->G) which led to aberrant splicing. Family 4 had known mutation in exon 19 (2053C-->T) in CpG mutation hotspot. The novel mutation of family 5 was an A deleted in a run of three As (1017-1019delA) in exon 10. In family 6, exons 2 and 3 were lost in BTK mRNA, a novel deletion. Family 7 had a novel substitution in exon 2 (227T-->C) which led to change of a conserved leucine to serine. Family 8 had a novel point mutation at beginning of intron 14 (IVS14+ 6 T-->G) resulting in aberrant splicing. Hum Mutat 15:385, 2000.

Original languageEnglish (US)
Number of pages1
JournalHuman mutation
Volume15
Issue number4
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Exons
Mutation
Point Mutation
Bruton type agammaglobulinemia
Agammaglobulinaemia tyrosine kinase
Initiator Codon
Plasma Cells
Leucine
Introns
Serine
B-Lymphocytes
T-Lymphocytes
Messenger RNA

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. / Yip, K. L.; Chan, S. Y.; Ip, Wai Kee Eddie; Lau, Y. L.

In: Human mutation, Vol. 15, No. 4, 01.01.2000.

Research output: Contribution to journalArticle

@article{d41b50798d704eea9dc4abca0cfae73a,
title = "Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.",
abstract = "Bruton's tyrosine kinase (BTK) is involved in B-cell development. Mutation of BTK results in X-linked agammaglobulinemia (XLA). BTK is expressed in most haemopoietic lineages except mature T cells and plasma cells. We identified six novel and two known mutations of BTK in 11 Chinese XLA patients from 8 families. Family 1 had a novel point mutation at the start codon (135G-->T) in exon 2. Family 2 had known mutation of single A insertion in a stretch of 7 A residues (341-347insA) recognized as mutation hotspot in exon 3. Family 3 had a novel point mutation in exon 11 (1074A-->G) which led to aberrant splicing. Family 4 had known mutation in exon 19 (2053C-->T) in CpG mutation hotspot. The novel mutation of family 5 was an A deleted in a run of three As (1017-1019delA) in exon 10. In family 6, exons 2 and 3 were lost in BTK mRNA, a novel deletion. Family 7 had a novel substitution in exon 2 (227T-->C) which led to change of a conserved leucine to serine. Family 8 had a novel point mutation at beginning of intron 14 (IVS14+ 6 T-->G) resulting in aberrant splicing. Hum Mutat 15:385, 2000.",
author = "Yip, {K. L.} and Chan, {S. Y.} and Ip, {Wai Kee Eddie} and Lau, {Y. L.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1002/(SICI)1098-1004(200004)15:4<385::AID-HUMU21>3.0.CO;2-D",
language = "English (US)",
volume = "15",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.

AU - Yip, K. L.

AU - Chan, S. Y.

AU - Ip, Wai Kee Eddie

AU - Lau, Y. L.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Bruton's tyrosine kinase (BTK) is involved in B-cell development. Mutation of BTK results in X-linked agammaglobulinemia (XLA). BTK is expressed in most haemopoietic lineages except mature T cells and plasma cells. We identified six novel and two known mutations of BTK in 11 Chinese XLA patients from 8 families. Family 1 had a novel point mutation at the start codon (135G-->T) in exon 2. Family 2 had known mutation of single A insertion in a stretch of 7 A residues (341-347insA) recognized as mutation hotspot in exon 3. Family 3 had a novel point mutation in exon 11 (1074A-->G) which led to aberrant splicing. Family 4 had known mutation in exon 19 (2053C-->T) in CpG mutation hotspot. The novel mutation of family 5 was an A deleted in a run of three As (1017-1019delA) in exon 10. In family 6, exons 2 and 3 were lost in BTK mRNA, a novel deletion. Family 7 had a novel substitution in exon 2 (227T-->C) which led to change of a conserved leucine to serine. Family 8 had a novel point mutation at beginning of intron 14 (IVS14+ 6 T-->G) resulting in aberrant splicing. Hum Mutat 15:385, 2000.

AB - Bruton's tyrosine kinase (BTK) is involved in B-cell development. Mutation of BTK results in X-linked agammaglobulinemia (XLA). BTK is expressed in most haemopoietic lineages except mature T cells and plasma cells. We identified six novel and two known mutations of BTK in 11 Chinese XLA patients from 8 families. Family 1 had a novel point mutation at the start codon (135G-->T) in exon 2. Family 2 had known mutation of single A insertion in a stretch of 7 A residues (341-347insA) recognized as mutation hotspot in exon 3. Family 3 had a novel point mutation in exon 11 (1074A-->G) which led to aberrant splicing. Family 4 had known mutation in exon 19 (2053C-->T) in CpG mutation hotspot. The novel mutation of family 5 was an A deleted in a run of three As (1017-1019delA) in exon 10. In family 6, exons 2 and 3 were lost in BTK mRNA, a novel deletion. Family 7 had a novel substitution in exon 2 (227T-->C) which led to change of a conserved leucine to serine. Family 8 had a novel point mutation at beginning of intron 14 (IVS14+ 6 T-->G) resulting in aberrant splicing. Hum Mutat 15:385, 2000.

UR - http://www.scopus.com/inward/record.url?scp=0034164667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034164667&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-1004(200004)15:4<385::AID-HUMU21>3.0.CO;2-D

DO - 10.1002/(SICI)1098-1004(200004)15:4<385::AID-HUMU21>3.0.CO;2-D

M3 - Article

C2 - 10737994

AN - SCOPUS:0034164667

VL - 15

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -